Studies of AIM2 on colorectal cancer lead to a similar conclusion with respect to the lack of AIM2 expression being closely correlated with unfavorable outcomes (Dihlmann et al., 2014; Liu et al., 2015a). This evidence concerns the gene AIM2 and colorectal cancer.